3.5.1 Respiratory stimulants

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

11 library items in 3.5.1 Respiratory stimulants

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

3: Respiratory system (remove) , 3.5 Respiratory stimulants and pulmonary surfactan (remove) , 3.5.1 Respiratory stimulants (remove)

Sort by: Display summary:

Results 1 - 10 of 11

Result page:
Previous
|
1
2
|
Next

1.

Data from long-term follow up of CAP trial evaluating neonatal caffeine therapy for apnoea of prematurity published

Source: JAMA,
Date published: 18/01/2012

Category:

3.5.1 Respiratory stimulants | Drugs in paediatrics | Neonatal and paediatric intensive care | Neonates (0-1 month) | Pre-term infants

NeLM Area:

News

Abstract

Editorial - extract
2.

RCT: Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO)

Source: Lancet,
Date published: 22/07/2010

Category:

3.5.1 Respiratory stimulants | 15.1.2 Inhalational anaesthetics | Pre-term infants | Respiratory Medicine

NeLM Area:

News

Abstract

Comment – full text (subscribers only)
3.

Updated national IV monograph on doxapram hydrochloride (Dopram®)

Source: Medusa,
Date published: 20/05/2010

Category:

3.5.1 Respiratory stimulants | Drug Administration

NeLM Area:

News

Link- registration required
4.

SMC accepts restricted use of caffeine base 5mg/mL (equivalent to caffeine citrate 10mg/mL) solution for injection for treatment of apnoea of prematurity

Source: Scottish Medicines Consortium (SMC),
Date published: 12/05/2009

Category:

3.5.1 Respiratory stimulants | Drug reviews | Drugs in paediatrics | Neonates (0-1 month) | Respiratory Medicine | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link
5.

Caffeine therapy for apnoea of prematurity is beneficial in the medium term

Source: N Engl J Med 2007; 357: 1893-902, 1967-8,
Date published: 08/11/2007

Category:

3.5.1 Respiratory stimulants | Infants (1-24 months) | Neonatal and paediatric intensive care | Neonates (0-1 month) | Respiratory Medicine

NeLM Area:

News

Editorial, link to extract

Abstract
6.

Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants

Source: Cochrane Database of Systematic Reviews,
Date published: 25/04/2006

Category:

3.5.1 Respiratory stimulants | Pre-term infants

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
7.

Inositol for respiratory distress syndrome in preterm infants

Source: Cochrane Database of Systematic Reviews,
Date published: 07/01/2004

Category:

2.6.4 Peripheral vasodilators and related drugs | 3.5.1 Respiratory stimulants | Neonates (0-1 month) | Respiratory Medicine

NeLM Area:

Evidence > Drug Specific Reviews

Abstract Link
8.

Doxapram injection - Antigen product is manufactured but not packed. Target for release is around 3 weeks.

Source: 0118 980 8600,
Date published: 18/06/2001

Category:

3.5.1 Respiratory stimulants

NeLM Area:

Other Library Updates > PaSA Updates

View complete report
9.

Doxapram injection – 5mL. Antigen has scheduled production.

Source: 0118 980 8600,
Date published: 09/05/2001

Category:

3.5.1 Respiratory stimulants

NeLM Area:

Other Library Updates > PaSA Updates

View complete report
10.

Doxapram injection 20mg/mL 5mL. Stocks of the Antigen product are almost exhausted.

Source: 0118 980 8600,
Date published: 21/03/2001

Category:

3.5.1 Respiratory stimulants

NeLM Area:

Other Library Updates > PaSA Updates

View complete report

Results 1 - 10 of 11

Result page:
Previous
|
1
2
|
Next